Literature DB >> 20020713

Oligomers of the prion protein fragment 106-126 are likely assembled from beta-hairpins in solution, and methionine oxidation inhibits assembly without altering the peptide's monomeric conformation.

Megan Grabenauer1, Chun Wu, Patricia Soto, Joan-Emma Shea, Michael T Bowers.   

Abstract

A portion of the prion protein, PrP106-126, is highly conserved among various species and is thought to be one of the key domains involving amyloid formation of the protein. We used ion mobility spectrometry-mass spectrometry (IMS-MS) in conjunction with replica exchange molecular dynamics (REMD) to examine the monomeric and oligomeric structures of normal PrP106-126 and two nonaggregating forms of the peptide, an oxidized form in which both methionine residues are oxidized to methionine sulfoxide and a control peptide consisting of the same amino acids as PrP106-126 in a scrambled sequence. Our ion mobility and simulation data indicate the presence of a population of beta-hairpin monomers for the normal and oxidized peptides. This is supported by our CD data indicating that a monomer solution of the normal peptide contains approximately 46% beta-sheet and approximately 23% beta-turn content, in excellent agreement with our REMD simulations. Oligomerization was seen by IMS-MS for the normal peptide only, not the oxidized peptide or the control sequence. Both our IMS-MS and CD data suggest that this oligomerization results from the association of ordered beta-hairpin monomers rather than disordered monomers. Structural analysis shows that the normal and oxidized peptides have similar secondary and tertiary structural properties, suggesting that the inhibition of aggregation caused by methionine oxidation stems from mediating interpeptide interactions rather than by altering the peptide's monomeric conformation. In contrast, an increase in alpha-helical and random coil structural components relative to the normal peptide might be responsible for the lack of observed aggregation of the control peptide.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20020713     DOI: 10.1021/ja905595k

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  19 in total

1.  Mass spectrometry and the amyloid problem--how far can we go in the gas phase?

Authors:  Alison E Ashcroft
Journal:  J Am Soc Mass Spectrom       Date:  2010-03-09       Impact factor: 3.109

2.  Number of solution states of bradykinin from ion mobility and mass spectrometry measurements.

Authors:  Nicholas A Pierson; Liuxi Chen; Stephen J Valentine; David H Russell; David E Clemmer
Journal:  J Am Chem Soc       Date:  2011-08-15       Impact factor: 15.419

Review 3.  Amyloid β Protein and Alzheimer's Disease: When Computer Simulations Complement Experimental Studies.

Authors:  Jessica Nasica-Labouze; Phuong H Nguyen; Fabio Sterpone; Olivia Berthoumieu; Nicolae-Viorel Buchete; Sébastien Coté; Alfonso De Simone; Andrew J Doig; Peter Faller; Angel Garcia; Alessandro Laio; Mai Suan Li; Simone Melchionna; Normand Mousseau; Yuguang Mu; Anant Paravastu; Samuela Pasquali; David J Rosenman; Birgit Strodel; Bogdan Tarus; John H Viles; Tong Zhang; Chunyu Wang; Philippe Derreumaux
Journal:  Chem Rev       Date:  2015-03-19       Impact factor: 60.622

4.  Role of β-hairpin formation in aggregation: the self-assembly of the amyloid-β(25-35) peptide.

Authors:  Luca Larini; Joan-Emma Shea
Journal:  Biophys J       Date:  2012-08-08       Impact factor: 4.033

5.  Regulation of the aggregation behavior of human islet amyloid polypeptide fragment by titanocene complexes.

Authors:  Weihong Du; Gehui Gong; Wenji Wang; Jufei Xu
Journal:  J Biol Inorg Chem       Date:  2017-08-11       Impact factor: 3.358

6.  Ion mobility spectrometry: A personal view of its development at UCSB.

Authors:  Michael T Bowers
Journal:  Int J Mass Spectrom       Date:  2014-09-15       Impact factor: 1.986

7.  Z-Phe-Ala-diazomethylketone (PADK) disrupts and remodels early oligomer states of the Alzheimer disease Aβ42 protein.

Authors:  Xueyun Zheng; Megan M Gessel; Meagan L Wisniewski; Kishore Viswanathan; Dennis L Wright; Ben A Bahr; Michael T Bowers
Journal:  J Biol Chem       Date:  2012-01-17       Impact factor: 5.157

8.  Influence of methionine-ruthenium complex on the fibril formation of human islet amyloid polypeptide.

Authors:  Gehui Gong; Jufei Xu; Xiangyi Huang; Weihong Du
Journal:  J Biol Inorg Chem       Date:  2019-01-30       Impact factor: 3.358

9.  Molecular insights into the reversible formation of tau protein fibrils.

Authors:  Yin Luo; Paul Dinkel; Xiang Yu; Martin Margittai; Jie Zheng; Ruth Nussinov; Guanghong Wei; Buyong Ma
Journal:  Chem Commun (Camb)       Date:  2013-05-04       Impact factor: 6.222

Review 10.  Alzheimer's disease Aβ assemblies mediating rapid disruption of synaptic plasticity and memory.

Authors:  Igor Klyubin; William K Cullen; Neng-Wei Hu; Michael J Rowan
Journal:  Mol Brain       Date:  2012-07-17       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.